Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Comparison of Timing and Image Quality of Different Phases of Optos Fluorescein Angiography Between Two Doses of Intravenous Fluorescein: 250mg Versus 500mg

NCT03244982 is registered in ClinicalTrials.gov with Kresge Eye Institute as lead sponsor.

NCT NCT03244982
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03244982 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Comparison of Timing and Image Quality of Different Phases of Optos Fluorescein Angiography Between Two Doses of Intravenous Fluorescein: 250mg Versus 500mg
Lead sponsor
Kresge Eye Institute
Phase
Phase 4
Overall status
Suspended
Start date
April 5, 2018
Completion date
December 1, 2020
Enrollment
79 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

fluorescein angiography